Tag: Clots
Forgoing Bridging Anticoagulation Noninferior in A-Fib
Findings in patients with atrial fibrillation undergoing elective operation, invasive procedure
Use of Novel Oral Anticoagulants Increasing in A-Fib
Findings in patients with atrial fibrillation hospitalized for stroke or transient ischemic attack
Younger Adults Receiving Excess Anticoagulant Dosing in PCI
Excess dosing for 42.7 percent during PCI; trend toward link between excess dosing, bleeding
Venous Thromboembolism Rates Low After Colorectal Surgery
No decrease in rates despite increased use of perioperative, in-hospital VTE chemoprophylaxis
Anticoagulation Appears Safe for Patients With Brain Mets
Treatment does not cause significant increase in incidence of intracranial hemorrhage
Most ER Patients With Low-Risk PE Eligible for Outpatient Tx
Increased frequency of 30-day adverse events for patients with contraindications to outpatient tx
Weight-Based Enoxoparin Dosing Best for Obese After C-Section
Weight-based dosing more effective than BMI-based dosing for venous thromboembolism prophylaxis
Higher Risk of VTE With Newer Forms of Oral Contraceptives
Includes brands such as Yaz, Yasmin, Desogen; risk to any one user remains very low
Many Incidental Findings From CT Angiography for Suspected PE
Value of incidental diagnoses unclear
Enoxaparin Prevents VTEs in Advanced Pancreatic Cancer
Enoxaparin effective for preventing VTEs with no adverse effect on major bleeding, chemo efficacy
